Companies Related to "Inovio Pharmaceuticals Report Fourth Quarter Year 2016 Financial" [Most Relevant Company Matches] - Page: 19 RSS

11:04 EDT 26th March 2019 | BioPortfolio

Here are the most relevant search results for "Inovio Pharmaceuticals Report Fourth Quarter Year 2016 Financial" found in our extensive corporate database of over 50,000 company records.

Showing "Inovio Pharmaceuticals Report Fourth Quarter Year 2016 Financial" Companies 451–475 of 5,400+

Probably Relevant

Center for Responsible Lending

The Center for Responsible Lending is a nonprofit, nonpartisan research and policy organization dedicated to protecting homeownership and family wealth by working to eliminate abusive financial practices. CRL is affiliated with Self-Help, one of the nation's largest community development financial institutions.

Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc., through its wholly-owned subsidiary in China, develops, manufactures and markets pharmaceutical products for a variety of diseases and conditions. The Company's most popular product is its Xin-Aoxing Oleanolic Acid Capsule, an over-the-counter ("OTC") medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. In addition to...

Macrolide Pharmaceuticals

Macrolide Pharmaceuticals focuses on the discovery and development of novel macrolide antibiotics for the treatment of life-threatening bacterial infections caused by drug resistant pathogens. Using novel technology, Macrolide Pharmaceuticals can synthesize a broad range of macrolides, and initial compounds show promising anti-bacterial activity. The compa...

Magainin Pharmaceuticals Inc.

Magainin Pharmaceuticals Inc. is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. Research and development efforts in anti-angiogenesis, obesity, infectious diseases and respiratory diseases.

AVEO Pharmaceuticals, Inc.

OSI Pharmaceuticals is committed to “shaping medicine and changing lives” by discovering, developing and commercializing high-quality, novel and differentiated targeted medicines designed to extend life and improve the quality of life for patients with cancer and diabetes/obesity.

Fovea Pharmaceuticals SA

Fovea Pharmaceuticals SA (Fovea) is a privately-held biopharmaceutical company specialized in development and commercialization of drugs for the treatment of ocular diseases, with a special focus on retinal pathologies. It has raised two rounds of financing. For more information, please visit .

Endo Pharmaceuticals

Endo Pharmaceuticals are a specialty pharmaceutical company engaged in the research, development, sale and marketing of prescription pharmaceuticals used primarily to treat and manage pain.

Lightyear Capital

Lightyear Capital is a leading private equity firm making primarily control investments in North America based, middle-market financial services companies. Based in New York, Lightyear, through its affiliated funds, has managed approximately $3 billion of committed capital with investments across the financial services spectrum, including asset management,...

Medytox, Inc.

Medytox, Inc. is the only biopharmaceutical company in the world to have three different types of botulinum toxin products (Neuronox, INNOTOX, Coretox), and Neuronox is only the fourth botulinum toxin therapeutic product approved anywhere in the world. All products have been developed by in-house R&D. Since the approval of Neuronox, Medytox has continued m...


Engitix was established in 2016 to develop and commercialise research at the UCL Institute for Liver and Digestive Health, Division of Medicine. The Company was founded by Professor Massimo Pinzani and Dr Giuseppe Mazza and has an exclusive license from UCLB to enabling ECM patents and other intellectual property. Engitix is based at the Royal Free Hospital ...

Praecis Pharmaceuticals Incorporated (MA)

PRAECIS PHARMACEUTICALS INCORPORATED is a biotechnology company focused on the discovery and development of pharmaceutical products using its proprietary LEAP™ (Ligand Evolution to Active Pharmaceuticals) technology. LEAP combines the power of biological selection with the advantages of medicinal chemistry in a unique molecular evolution process. PRAECIS employed LEAP in the development of PLENA...

Osprey Pharmaceuticals U.S.A., Inc.

Osprey Pharmaceuticals U.S.A. is focused on the development of protein therapeutics for the treatment of inflammatory and autoimmune conditions based on the company's proprietary therapeutic platform of Leukocyte Population Modulators (LPMs). Osprey Pharmaceuticals U.S.A. is advancing a pipeline of proprietary LPMs, novel fusion protein therapeutics designed to selectively and systematically neutr...


Driscoll’s is a fourth generation, family-owned company that has been involved in berry farming for more than 100 years. As the leading provider of fresh and organic berries, Driscoll’s works with independent farmers to produce the highest-quality strawberries, raspberries, blackberries and blueberries in the world, in an effort to continually de...

Prudential Financial, Inc.

Prudential Financial, Inc. (NYSE: PRU), a financial services leader with approximately $859 billion of assets under management as of March 31, 2011, has operations in the United States, Asia, Europe, and Latin America. Prudential’s diverse and talented employees are committed to helping individual and institutional customers grow and protect their wea...


Launched in 1999, InvestorWords is the premier financial glossary on the web, helping millions of individuals understand and keep up-to-date with the terms that they need to know in order to succeed in today’s financial world.This glossary is a great learning tool, as it is comprehensive and easy to navigate. InvestorWords currently has 6,000 definitions, and new terms are added frequently. Also...

Synovics Pharmaceuticals

Synovics is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of oral controlled-release generic drugs and improved formulations of previously approved drugs. The Company has licensed exclusive and worldwide rights to employ certain proprietary oral controlled-release drug formulation technologies. Synovics is undertaking the initiation of US develo...

EMD Pharmaceuticals

We are EMD Pharmaceuticals, a company focused on developing products and services for people suffering from cancer and other serious medical conditions. Our commitment to the pharmaceutical industry goes beyond the development of breakthrough treatments; we believe we should play a larger role in supporting people with unmet medical needs and their healthcare providers.

Sideris Pharmaceuticals, Inc.

Sideris Pharmaceuticals Inc. is a privately held biopharmaceutical company that is focused on development of therapeutics for the treatment of transfusion-related iron overload. The company’s operations include facilities in Boston, MA, and in Gainesville, FL. For additional information please visit our website at


MoneyGram, a leading global money transfer company, enables consumers who are not fully served by traditional financial institutions to meet their financial needs. MoneyGram offers money transfer services worldwide and bill payment services in the United States and Canada through a global network of more than 334,000 agent locations—including retailer...

Samaritan Pharmaceuticals

Samaritan Pharmaceuticals is a biopharmaceutical company focused on saving lives utilizing Samaritan Laboratories, Georgetown University's School of Medicine, to identify and design drugs for Alzheimer's, AIDS, cancer and cholesterol and process resulting "drug candidates" through the FDA to obtain approval.


It all comes down to three little words for us. Meetings doctors love. We are passionate in our commitment to creating truly distinctive meetings for pharmaceutical companies and the physicians they value dearly. We treat each attendee as a distinguished guest and as an individual - so they go out of their way to return to your meetings year after year.An honest commitment to personalized service,...

Parnell Pharmaceuticals, Inc.

Parnell Pharmaceuticals is the first company dedicated to the research and development of new and innovative products to restore and maintain mucosal integrity. Employing a proprietary and patented technology, Parnell Pharmaceuticals’ products contain Yerba Santa, which containts natural mucopolysaccharides and glycoproteins.The yerba santa plant, native to the foothills of the Pacific Nort...

Syros Pharmaceuticals

Syros Pharmaceuticals is a life sciences company harnessing breakthroughs in gene control to revolutionize the treatment of cancer and other diseases. Syros’ proprietary platform identifies the master switches for disease genes, opening a whole new approach to novel therapeutics. Syros’ initial focus is in cancer, but the company platform will al...

OncoImmune, Inc.

OncoImmune ( is a privately-held, clinical-stage biopharmaceutical company that is actively engaged in the discovery and development of novel immunotherapies for cancer, inflammation and autoimmune diseases. OncoImmune entered into a license and option agreement in 2016 with Pfizer Inc. regarding ONC-392, a pre-clinical IO program. OncoI...

Enta Technologies Ltd

Entanet is a leading business ISP supplying broadband and business solutions through over 300 channel partners.Established in 1996, the company has enjoyed consistent and significant year-on-year growth, both in terms of channel partner numbers and revenue. Today it employs over 40 sales, admin, support and technical staff and has a turnover of approximately £11 million.

More From BioPortfolio on "Inovio Pharmaceuticals Report Fourth Quarter Year 2016 Financial"

Quick Search


Corporate Database Quicklinks